Dergiler / Türk Toraks Dergisi / 2014 / Cilt: 15 - Sayı: 4

A Rare adverse event induced by theophylline: Epilepsy

Sayfa
172–174
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In this case report, we want to share our experience with a patient who developed partial epilepsy during intravenous theophylline application.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Despite its poor effcacy, theophylline, which is a methylxanthine derivative, is being commonly used for the treatment of chronic obstructive pulmonary disease (COPD) worldwide for many years due to its low cost.
📊
Temel Bulgular & Veri:This drug with bronchodilator activity must be carefully used in the elderly.
💡
Sonuç & Katkı:In this case report, we want to share our experience with a patient who developed partial epilepsy during intravenous theophylline application.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Despite its poor effcacy, theophylline, which is a methylxanthine derivative, is being commonly used for the treatment of chronic obstructive pulmonary disease (COPD) worldwide for many years due to its low cost. This drug with bronchodilator activity must be carefully used in the elderly. In this case report, we want to share our experience with a patient who developed partial epilepsy during intravenous theophylline application.

🔖

Bu Makaleye Atıf Yap

BATUM, Ö., BATUM, M. (2014). A Rare adverse event induced by theophylline: Epilepsy. Türk Toraks Dergisi, Cilt: 15 - Sayı: 4, 172–174. https://ajindex.com/articles/329479

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Charehsaz M, Gürbay A, Karakılıç E, Şahin G. Theophylline: Ad - verse effects, poisoning and treatment approaches. J Clin Anal Med 2011;2:157-63. [CrossRef] 2. Abernethy DR, Arnold GJ, Azarnoff D, editors. Mosby’s Drug Consult. St. Louis: Mosby Inc, 2002. 3. Sifton DJ, editor. Physicians Desk Reference. 57th ed. Montvale: Thomson PDR; 2003. 4. Abernethy DR, Arnold GJ, Azarnoff D, editors. Mosby’s Drug Consult. St. Louis: Mosby Inc, 2002. 5. Barnes PJ. Theophylline in chronic obstructive pulmonary disease: new horizons. Proc Am Thorac Soc 2005;2:334-40. [CrossRef] 6. Kayaalp SO, editor. Medical Pharmacology Regarding the Ra - tional Treatment.11th ed. Ankara: Hacettepe-Taş Kitapçılık, 2005. 7. Rotella DP. Phosphodiesterase enzymes- Target overwiev. Touch Briefngs. Drug Discovery. 2007;22-3. 8. Yaguchi M, Yaguchi H. A case of theophylline-associated sei- zures with postictal fever and postictal pleocytosis. Brain Nerve 2010;62:1089-93. 9. Boison D. Methylxanthines, seizures, and excitotoxicity. Handb Exp Pharmacol 2011:251-66. 10. Koizumi S, Saito K. Theophylline-induced changes in mouse electroencephalograms Brain Dev 2010;32:818-20. [CrossRef]